This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5097846

PUBLISHED SUBJECT

LEVOSSIMEDANO 2,5MG/ML SOL INJ ,FR 5ML IV OCTREOTIDO,0,1MG/ ML SOL INJ FR 1 ML IV SC INFLIXIMAB,100MG,PÓ CONC SOL INJ FR IV Imunoglobulina humana normal 100 mg/ml Sol inj Fr 200 ml IV

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
Pharmis Biofarmaceuticas Lda · Tax ID 502595442
Awardee
OCTAFHARMA- PROD. FARMACEUTICO · Tax ID 502820780
Awardee
ORIONFIN UNIPESSOAL LDA. · Tax ID 508907365
Awardee
PHARMAKERN PORTUGAL PROD.FARMACEUTICO · Tax ID 507002571

Values and timeline

Contract price
€83,112.82
Procedure base price
€83,112.82
Total effective price
Not reported on Portal BASE
Publication date
5 January 2019
Award date
17 December 2018
Signing date
17 December 2018
Performance period
10 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2017/9 - Acordo quadro para fornecimento de Derivados do Plasma Humano às Instituições e Serviços do Serviço Nacional de Saúde
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3759601

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts